Minimal atrophy of the entorhinal cortex and hippocampus: Progression of cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 31, Issue 4, 2011, Pages 276-283

  Varon, Daniel ^a,d   Loewenstein, David A ^a,c   Potter, Elizabeth ^a   Greig, Maria T ^a   Agron, Joscelyn ^a   Shen, Qian ^a,e   Zhao, Weizhao ^e   Celeste Ramirez, Maria ^a   Santos, Isael ^a   Barker, Warren ^a   Potter, Huntington ^f   Duara, Ranjan ^a,b,c,d,f  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Departments of Medicine and Neurology   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e University of Miami College of Engineering   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer disease; Brain MRI; Cognitive and functional impairment; Dementia; Entorhinal and hippocampal atrophy; Progression; Visual rating

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; COGNITION DISORDERS; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79953865830     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324711     Document Type: Article

References (44)

1. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ: Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119-128.
2. Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A: Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002; 59: 1729-1734. (Pubitemid 35340483)
3. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K: CSF Biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009; 302: 385-393.
4. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319. (Pubitemid 38269583)
5. Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA: APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010; 67: 122-131.
6. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
7. Konrad C, Ukas T, Nebel C, Arolt V, Toga AW, Narr KL: Defining the human hippocampus in cerebral magnetic resonance images - an overview of current segmentation protocols. Neuroimage 2009; 47: 1185-1195.
8. Price CC, Wood MF, Leonard CM, Towler S, Ward J, Montijo H, Kellison I, Bowers D, Monk T, Newcomer JC, Schmalfuss I: Entorhinal cortex volume in older adults: reliability and validity considerations for three published measurement protocols. J Int Neuropsychol Soc 2010; 16: 846-855.
9. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool: Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 1995;242:557-560.
10. Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H: Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008; 71: 1986-1892.
11. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-1403. (Pubitemid 29190530)
12. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E: Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 484-489. (Pubitemid 30647242)
13. Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ: Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 2004; 63: 2354-2359. (Pubitemid 40024349)
14. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ: Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007; 68: 828-836. (Pubitemid 46568534)
15. Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version; in Brink TL (ed): Clinical Gerontology: A Guide to Assessment and Interventions. New York, Haworth Press, 1986, pp 165-173. (Pubitemid 17221439)
16. Cummings JL, Mega M, Gray K, Rosenberg- Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of neuropathology in dementia. Neurology 1994; 44: 2308-2314. (Pubitemid 24382728)
17. Morris JC: The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993; 43: 2412-2414. (Pubitemid 23346995)
18. Folstein M, Folstein S, McHugh P: Mini- Mental State: a practical method for grading the cognitive state of patients for the physician. J Psychiatr Res 1975; 12: 189-198.
19. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC: The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009;23:91-101.
20. Fuld PA: Fuld Object-Memory Evaluation. Wood Dale, Stoelting, 1981.
21. Brant J, Benedict R: Hopkins Verbal Learning Test-Revised. Odessa, Psychological Assessment Resources, 2001.
22. Fahn S, Elton R: Unified Parkinson's disease rating scale; in Fahn S, Marsden D, Calne D (eds): Recent Developments in Parkinson Diseases . London, Macmillan, 1987, pp 153- 163.
23. Duara R, Loewenstein DA, Greig M, Acevedo A, Potter E, Appel J, Raj A, Schinka J, Schofield E, Barker W, Wu Y, Potter H: Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multi-center research studies. Am J Geriatr Psychiatry 2010; 18: 363-370.
24. Storandt M, Grant EA, Miller JP, Morris JC: Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology 2006; 67: 467-473. (Pubitemid 44214972)
25. Loewenstein DA, Acevedo A, Ownby R, Agron J, Barker WW, Isaacson R, Strauman S, Duara R: Using different memory cut-offs to assess mild cognitive impairment. Am J Geriatric Psych 2006; 14: 911-919. (Pubitemid 44706409)
26. Loewenstein DA, Acevedo A, Agron J, Martinez G, Duara R: The use of amnestic and nonamnestic composite measures at different thresholds in the neuropsychological diagnosis of MCI. J Clin Exp Neuropsychol 2007; 29: 300-307. (Pubitemid 46598771)
27. Wechsler D: The Wechsler Adult Intelligence- Revised. New York, Psychological Corporation, 1981.
28. Acevedo A, Loewenstein DA, Barker WW, Harwood DG, Luis C, Bravo M, Hurwitz DA, Aguero H, Greenfield L, Duara R: Category fluency test: normative data for English- and Spanish-speaking elderly. J Int Neuropsychol Soc 2000; 6: 760-769.
29. Spreen O, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, ed 2. New York, Oxford University Press, 1998.
30. Wechsler D: The Wechsler Adult Intelligence- Revised. New York, Psychological Corporation, 1981.
31. Wechsler D: The Wechsler Adult Intelligence Scale, ed 3. San Antonio, Psychological Corporation, 1997.
32. McKhann G, Drachman DA, Folstein MF, Katzman R, Price DL, Stadlan E: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
33. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308. (Pubitemid 29120227)
34. Urs R, Potter E, Barker W, Appel J, Loewenstein DA, Zhao W, Duara D: Visual rating system (VRS) for assessing magnetic resonance images (MRIs): a tool in the diagnosis of MCI and Alzheimer's disease. J Comput Assist Tomogr 2009; 33: 73-78.
35. Alemán-Gómez Y, Melie-García L, Valdés- Hernandez P. IBASPM: Toolbox for automatic parcellation of brain structures. Presentation, 12th Ann Meet Organ Human Brain Mapping, June 11-15, 2006, Florence. Available on CD-ROM NeuroImage 2005; 27(1).
36. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159.
37. Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe C, Australian Imaging Biomarkers and Lifestyle Research Group: Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 2010; 67: 317-324.
38. Geuze E, Vermetten E, Bremner JD: MRbased in vivo hippocampal volumetrics. 2. Findings in neuropsychiatric disorders. Mol Psychiatry 2005; 10: 160-184. (Pubitemid 40188512)
39. Braak H, Alafuzoff I, Arzberger T, Kretz schmar H, Del Tredici K: Acta staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Neuropathology 2006; 112: 389-404. (Pubitemid 44469160)
40. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS: MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002; 58: 1188-1196. (Pubitemid 34411862)
41. Jauhiainen AM, Pihlajamäki M, Tervo S, Niskanen E, Tanila H, Hänninen T, Vanninen RL, Soininen H: Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment. Hippocampus 2009; 192: 166-175.
42. Desikan RS, Cabral HJ, Fischl B, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ: Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease. AJNR Am J Neuroradiol 2009; 30: 532-538.
43. Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ: MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 2008; 71: 819-825.
44. Nagy Z, Esiri MM, Hindley NJ, et al: Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dement Geriatr Cogn Disord 1998; 9: 219-226. (Pubitemid 28279616)